“At Beiersdorf, we have many years of expertise
when it comes to decoding the complex processes of the skin on the basis of new
findings and technologies. Our Research & Development department has driven
innovative developments and set milestones, particularly in the field of skin aging.
We have done pioneering work in discovering the importance of Q10 in skin aging
and finally making the skin’s own Q10 available as an active ingredient for the
first time,“ explains Dr. Gitta Neufang, Corporate Senior Vice President
Research & Development and head of more than 1,000 Beiersdorf researchers
worldwide. To this day, coenzyme Q10 remains one of the most important active
ingredients in the anti-aging field. “After launching the first Q10 skin care
products on the mass market under the NIVEA brand more than 25 years ago, we
are now taking another decisive step in the anti-aging segment with our new
anti-glycation ingredient. We’ve spent around ten years intensively researching
glycation in the skin and searching for an effective active ingredient,“
adds Gitta Neufang. ”In total, our team tested around 1,700 active ingredients.
Many substances intercept the sugar before it can react; they sacrifice
themselves and become saccharified. This effect has to be avoided,“ says Dr
Julia Weise, laboratory manager in the Biological Testing department at
Beiersdorf. “Ultimately, there was a clear “winning ingredient” called NAHP,
which stands for N-Acetyl-L-hydroxyproline. ”NAHP prevents the glycation
reaction from taking place in the first place and prevents the formation of
AGEs at a higher rate – by up to 68%. Sugar molecules are neutralized before
they can bind to proteins and weaken collagen fibers, for example1.
This is why we have given our active ingredient NAHP the second name ‘Glycostop.’
We have a patent for its use in cosmetic products and have published several
scientific papers on the subject2,“
explains Julia Weise.